Merck (MRK) analyst forecast and price target
Analyst forecast
Consensus of 31 analyst ratings
Based on 16 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | SectorPerform → Sector Perform | $145.00 from $150.00 | Oct 12, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $145.00 from $120.00 | Oct 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $177.00 from $179.00 | Oct 7, 2026 |
| JP Morgan | Maintained | Overweight | $165.00 from $150.00 | Oct 5, 2026 |
| Scotiabank | Maintained | Sector Outperform | $180.00 from $155.00 | Sep 29, 2026 |
| HSBC | Maintained | Buy | $172.00 from $150.00 | Sep 10, 2026 |
| Leerink Partners | Maintained | Outperform | $161.00 from $127.00 | Sep 9, 2026 |
| Guggenheim | Maintained | Buy | $170.00 from $146.00 | Sep 8, 2026 |
| Wells Fargo | Maintained | Overweight | $170.00 from $150.00 | Sep 4, 2026 |
| Argus Research | Maintained | Buy | $170.00 from $145.00 | Aug 25, 2026 |
| Wolfe Research | Maintained | Outperform | $180.00 from $155.00 | Aug 25, 2026 |
| Goldman Sachs | Maintained | Buy | $160.00 from $140.00 | Aug 21, 2026 |
| Morgan Stanley | Upgraded | Equal-Weight → Overweight | $179.00 from $116.00 | Aug 20, 2026 |
| RBC Capital | Downgraded | Outperform → Sector Perform | $150.00 from $142.00 | Aug 20, 2026 |
| UBS | Maintained | Buy | $175.00 from $145.00 | Aug 20, 2026 |
| BMO Capital | Maintained | Outperform | $170.00 from $142.00 | Aug 20, 2026 |
| Daiwa Capital | Upgraded | Neutral → Outperform | $143.00 from $120.00 | Aug 12, 2026 |
| Argus Research | Maintained | Buy | $145.00 from $130.00 | Aug 11, 2026 |
| Guggenheim | Maintained | Buy | $146.00 from $145.00 | Aug 5, 2026 |
| Barclays | Maintained | Overweight | $150.00 from $140.00 | Jul 29, 2026 |
Frequently asked questions
What is the price target for MRK stock?
The average 12-month analyst price target for Merck (MRK) is $164.56, with a high estimate of $180.00 and a low of $143.00, across 16 analysts.
Is MRK a buy, sell, or hold?
Analysts covering Merck currently average a Buy rating: 21 buy, 9 hold and 1 sell, from 31 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for MRK?
The average price target of $164.56 implies 13.45% upside from the last price of $145.06.
What is the latest analyst rating on MRK?
On Oct 12, 2026, RBC Capital maintained Merck at Sector Perform with a price target of $145.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.